Antibody drug lowers risk of death in elderly coronavirus patients: Study

Biocon Ltd received regulatory approval in India for itolizumab for use in coronavirus infected patients.Researchers, which developed itolizumab, said timely use of the drug in combination with standard therapy helped reduce inflammation and prevented COVID-19 from worsening

from Livemint - Science https://ift.tt/2PnRBGZ
https://ift.tt/eA8V8J